A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
11/2004
11/03/2004	EP1473294A2 Substituted 1,3-oxathiolanes with antiviral properties
11/03/2004	EP1473037A1 Treatment of hPMV infections with Ribavirin
11/03/2004	EP1472540A2 Methods and compositions in treating pain and painful disorders using 1465,1587, 2146, 2207, 32838, 336 and 52908
11/03/2004	EP1472364A2 Truncated aggrecanase molecules
11/03/2004	EP1472353A2 Group b streptococcus antigen
11/03/2004	EP1472344A2 Novel protein
11/03/2004	EP1472341A2 Compositions and methods for restoring immune responsiveness in patients with immunological defects
11/03/2004	EP1472279A1 A method for inhibiting "melanoma inhibitory activity" mia
11/03/2004	EP1472278A2 Macrocyclic peptides active against the hepatitis c virus
11/03/2004	EP1472269A1 RNA INTERFERENCE MEDIATED INHIBITION OF INTERLEUKIN GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)
11/03/2004	EP1472267A2 Rna interference mediated inhibition of protein tyrosine phosphatase type iva (prl3) gene expression using short interfering nucleic acid (sina)
11/03/2004	EP1472260A2 Thieno(3,2-b)pyridones as antiviral compounds
11/03/2004	EP1472257A1 Inhibitors of alpha l beta 2 integrin mediated cell adhesion
11/03/2004	EP1472254A2 Purine and isosteric antibacterial compounds
11/03/2004	EP1472247A1 Antimicrobial thiadiazinone derivatives useful in treatment of bacterial infections
11/03/2004	EP1472244A1 Aromatic sulfone hydroxamic acids and their use as protease inhibitors
11/03/2004	EP1472243A1 Piperidine derivatives and their use as antagonists of tachykinins
11/03/2004	EP1472241A1 Cytoprotective benzofuran derivatives
11/03/2004	EP1472230A2 Ansamycins having improved pharmacological and biological properties
11/03/2004	EP1472229A1 5-ring heterocycles used as antiviral agents
11/03/2004	EP1472224A2 3-alkanoylamino-propionic acid derivatives used as inhibitors of integrin avss6
11/03/2004	EP1472221A2 Substituted indoles, method for production and use thereof for the inhibition of pain
11/03/2004	EP1472209A2 Lipoxin a4 analogs
11/03/2004	EP1471970A2 NOVEL MAMMALIAN MULTIPOTENT STEM CELLS AND COMPOSITIONS, METHODS OF PREPARATION AND METHODS OF ADMINISTRATION THEREOF
11/03/2004	EP1471938A2 Human monoclonal antibodies against cd30
11/03/2004	EP1471937A1 A continuous cell line for the production of vaccines
11/03/2004	EP1471933A1 Albumin-fused anti-angiogenesis peptides
11/03/2004	EP1471928A1 Hiv inhibiting proteins
11/03/2004	EP1471927A2 Diagnostics and therapeutics for diseases associated with neuromedin u1 receptor (nmu1)
11/03/2004	EP1471925A2 Inorganic nanoparticles to modify the viscosity and physical properties of ophthalmic and otic compositions
11/03/2004	EP1471923A1 Amido macrolides
11/03/2004	EP1471918A2 Use of modified pyrimidine compounds to promote stem cell migration and proliferation
11/03/2004	EP1471911A1 Novel crystalline forms of gatifloxacin
11/03/2004	EP1471910A2 Substituted quinazolin-4-ylamine analogues as modulators of capsaicin receptors
11/03/2004	EP1471887A2 Nanoparticulate compositions having lysozyme as a surface stabilizer
11/03/2004	EP1471873A2 Flavivirus vaccines
11/03/2004	EP1471872A2 Treatment of colds and cough with a combination of a cyclooxygenase-2 selective inhibitor and a colds and cough active ingredient and compositions thereof
11/03/2004	EP1471870A2 Use of lipid conjugates in the treatment of disease
11/03/2004	EP1235814B1 3,4-DIHYDRO-(1H)QUINAZOLIN-2-ONE COMPOUNDS AS CSBP/p38 KINASE INHIBITORS
11/03/2004	EP1207907B1 Compositions for treating viral infections, and methods therefor
11/03/2004	EP1131094B1 Multivalent t.d. polio vaccine against at least diphtheria, poliomyelitis and tetanus
11/03/2004	EP1105371B1 Novel aryl sulphonamide amino acid esters and analogues
11/03/2004	EP0956021B1 L-beta-dioxolane uridine analogs for treating and preventing infections by ebv, vzv and hv-8
11/03/2004	EP0788305B1 Composition for inactivating irritants in fluids
11/03/2004	EP0698101B1 Hepatitis-c virus type 4, 5 and 6
11/03/2004	CN1543569A Cross-reactive monoclonal and polyclonal antibodies which recognize surface proteins from coagulase-negative staphylococci and staphylococcus aureus
11/03/2004	CN1543502A CD8 alpha + lymphoid dendritic cell differentiated from human hematopoietic stem cell and a method for differentiation
11/03/2004	CN1543501A Method of extended culture for antigen-specific cytotoxic t lymphocytes
11/03/2004	CN1543472A 6-o-carbamoyl ketolide antibacterials
11/03/2004	CN1543465A Novel heterocyclic compounds as selective bacterial DHFR inhibitors and their uses thereof
11/03/2004	CN1543464A Novel imidazopyridine compounds with therapeutic effect
11/03/2004	CN1543461A Melanocortin receptor ligands
11/03/2004	CN1542136A Method for production of cytosporasp B and the use in preparation of anti-tumor and antifungal medicine
11/03/2004	CN1542017A An antibiotic peptide and its coded sequence and use
11/03/2004	CN1542012A Cefetamet sodium and its application of preparing powder injection or dry powder injection for broad-spectrum strong antibiotic injection
11/03/2004	CN1542010A Azolo triazines and pyrimidines
11/03/2004	CN1542005A Preparation method and use of sulfalene oxazole derivative
11/03/2004	CN1542003A Preparation method and use of trimethoprim derivative
11/03/2004	CN1541713A Cross-breed vaccine carrier and its application
11/03/2004	CN1541711A Regulation of immune responses by manipulation of intermediary metabolite levels
11/03/2004	CN1541710A Bivalence polypeptide vaccine for resisting A type and O type foot-and-mouth disease virus and its preparation
11/03/2004	CN1541709A Polyepitope and composite polyepitope DNA vaccine of HIV
11/03/2004	CN1541707A Medicinal composition for treating serious acute respiratory syndrome
11/03/2004	CN1541691A Acute icterohepatitis treating Chinese traditional medicine and its preparation
11/03/2004	CN1541690A Chinese traditional medicine preparation Qimaishen for treating viral myocarditis and its manufacturing method
11/03/2004	CN1541688A Traditional Chinese medicine preparation for treating nonspecific colonitis and its preparing process
11/03/2004	CN1541679A Chinese traditional medicine preparation for preventing and treating bee diseases
11/03/2004	CN1541668A Osteopathy treating ointment
11/03/2004	CN1541665A Sustained release medicine for treating hepatitis and its preparing process
11/03/2004	CN1541652A Traditional Chinese medicine for treating upper respiratory tract infection and its preparation method
11/03/2004	CN1541651A Unit dosage glycyrrhizicacid diammonium freeze-dry powder injection formulation and its preparation method
11/03/2004	CN1541648A Sodium bisulfate andrographolide aseptic powder for injection and its preparation method
11/03/2004	CN1174097C Macrophage activating factors derived from cloned vitamin D binding protein
11/03/2004	CN1173979C Propenyl cephalosporin derivatives
11/03/2004	CN1173974C Piperidylaminomethyltrifluoromethyl cyclic ether compound as p substance antagonist
11/03/2004	CN1173971C Cycloalkyl-substituted aminomethylpyrrolidine derivatives
11/03/2004	CN1173969C Novel lipoic acid derivatives, their preparation method and medical use, and pharmaceutical compositions containing them
11/03/2004	CN1173738C Utilization of interferon alpha 5 in the preparation of drugs for viral hepatopathies
11/03/2004	CN1173737C Application of Hepcidin in pharmacy
11/03/2004	CN1173732C Traditional Chinese medicine pills for skin and venereal disease and urinary system infection
11/03/2004	CN1173731C Use of Traditonal Chinese medicine composition for curing chronic hepatitis B fibrosis in preparation of medicine for pulmonary fibrosis of SARS
11/03/2004	CN1173717C Tradtional Chinese medicine for treating tuberculosis
11/03/2004	CN1173705C Use of ª‰-2-hydroxymethyl-5-(5-fluctyosine-1-yl)-1,3-oxathialane in preparation of medicine and composition containing same
11/03/2004	CN1173695C Controlled release and odor masking oral pharmaceutical compositions
11/03/2004	CN1173690C Gargle with complex lysostaphin and its preparation
11/02/2004	US6812331 Aromatic derivatives substituted by a ribose, their preparation process and their use as medicaments
11/02/2004	US6812250 Carboxamide-substituted phenylurea derivatives, process for their preparation and their use as medicaments
11/02/2004	US6812245 Polycylic xanthones and their use
11/02/2004	US6812224 Phosphorous organic compounds and their use
11/02/2004	US6812219 Methods and compositions for treating flaviviruses and pestiviruses
11/02/2004	US6812209 Conjugate consisting of an active substance and a non-exogenous native protein
11/02/2004	US6812026 Antibodies directed against binding-associated epitopes
11/02/2004	US6812025 Detection of preferential enzyme inhibitors; obtain sample containing enzyme, incubate with modulator and nucleotide sequences, monitor amplification of preferential nucleotide sequences, absence of sequences indicates modulator
11/02/2004	US6812021 Isolated from streptococcus; for preparation of therapeutics (vaccines) to immunize against microbial infection; urinary tract infections; drug screening
11/02/2004	US6811787 Over-expressing homologous antigen vaccine and a method of making the same
11/02/2004	US6811784 Recombinant parainfluenza virus expression system and vaccines
11/02/2004	US6811780 Concurrent administering of cytokine antagonist and vaccine
11/02/2004	US6811775 Reovirus for the treatment of cellular proliferative disorders
11/02/2004	US6811767 Liquid droplet aerosols of nanoparticulate drugs
11/02/2004	CA2364251C Synergistic inhibition of viral replication by long-chain hydrocarbons and nucleoside analogs

1 ... 1025 1026 1027 1028 1029 1030 1031 1032 1033 1034 1035 1036 1037 1038 1039 1040 1041 1042 1043 1044 1045 ... 1798